| Neeraj Kumar Kalra, MD | |
|
5323 Harry Hines Blvd, Dallas, TX 75390-7208 | |
| (214) 648-9741 | |
| (214) 648-9531 |
| Full Name | Neeraj Kumar Kalra |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 25 Years |
| Location | 5323 Harry Hines Blvd, Dallas, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497731103 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 042676 (Connecticut) | Secondary |
| 208M00000X | Hospitalist | Q7216 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Parkland Health & Hospital System | Dallas, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Texas Southwestern Medical Center | 0648188250 | 2588 |
News Archive
MMR Information Systems, Inc. (OTCBB: MMRF) (the "Company"), which, through its wholly-owned operating subsidiary, MyMedicalRecords, Inc., provides consumer-controlled Personal Health Records (www.mymedicalrecords.com) and electronic safe deposit box storage solutions (www.myesafedepositbox.com), announced today that it has entered into an Investment Agreement (the "Agreement") for an $8,000,000 equity line of credit with Dutchess Equity Fund, LP ("Dutchess").
A new study published in April 2020 on the preprint server bioRxiv reports that the different levels of susceptibility of various organs to viral attack by the SARS-CoV-2 virus causing the huge pandemic of COVID-19 sweeping around the world can be predicted from the level of expression of two molecules, the ACE2 receptor, and the TMPRSS2 protein.
Academic and Community Cancer Research United (ACCRU) today announced the opening of a two-arm, randomized phase III, FDA registration trial of eribulin compared to standard weekly paclitaxel as first- or second-line chemotherapy for individuals with human epidermal growth factor receptor 2 (HER2) negative, locally recurrent, unresectable or metastatic breast cancer.
This research, published on Oct. 12 on the Nature review website, provides evidence of a major concept could pave the way for the future use of these stem cells to treat humans, through perspective gene therapies.
This week, Africa seizes an unprecedented chance to drive out polio when 15 countries across the continent launch a synchronized mass immunization campaign to reach 72 million children, capitalizing on gains made this year. A total of some 290 000 vaccinators have been mobilized to go door-to-door to deliver two drops of oral polio vaccine (OPV) to every child under five in areas considered at "highest risk" of polio transmission.
› Verified 7 days ago
| Entity Name | University Of Texas Southwestern Medical Center At Dallas |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972579365 PECOS PAC ID: 0648188250 Enrollment ID: O20031106000792 |
News Archive
MMR Information Systems, Inc. (OTCBB: MMRF) (the "Company"), which, through its wholly-owned operating subsidiary, MyMedicalRecords, Inc., provides consumer-controlled Personal Health Records (www.mymedicalrecords.com) and electronic safe deposit box storage solutions (www.myesafedepositbox.com), announced today that it has entered into an Investment Agreement (the "Agreement") for an $8,000,000 equity line of credit with Dutchess Equity Fund, LP ("Dutchess").
A new study published in April 2020 on the preprint server bioRxiv reports that the different levels of susceptibility of various organs to viral attack by the SARS-CoV-2 virus causing the huge pandemic of COVID-19 sweeping around the world can be predicted from the level of expression of two molecules, the ACE2 receptor, and the TMPRSS2 protein.
Academic and Community Cancer Research United (ACCRU) today announced the opening of a two-arm, randomized phase III, FDA registration trial of eribulin compared to standard weekly paclitaxel as first- or second-line chemotherapy for individuals with human epidermal growth factor receptor 2 (HER2) negative, locally recurrent, unresectable or metastatic breast cancer.
This research, published on Oct. 12 on the Nature review website, provides evidence of a major concept could pave the way for the future use of these stem cells to treat humans, through perspective gene therapies.
This week, Africa seizes an unprecedented chance to drive out polio when 15 countries across the continent launch a synchronized mass immunization campaign to reach 72 million children, capitalizing on gains made this year. A total of some 290 000 vaccinators have been mobilized to go door-to-door to deliver two drops of oral polio vaccine (OPV) to every child under five in areas considered at "highest risk" of polio transmission.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Neeraj Kumar Kalra, MD Po Box 845347, Dallas, TX 75284-5347 Ph: (214) 648-9741 | Neeraj Kumar Kalra, MD 5323 Harry Hines Blvd, Dallas, TX 75390-7208 Ph: (214) 648-9741 |
News Archive
MMR Information Systems, Inc. (OTCBB: MMRF) (the "Company"), which, through its wholly-owned operating subsidiary, MyMedicalRecords, Inc., provides consumer-controlled Personal Health Records (www.mymedicalrecords.com) and electronic safe deposit box storage solutions (www.myesafedepositbox.com), announced today that it has entered into an Investment Agreement (the "Agreement") for an $8,000,000 equity line of credit with Dutchess Equity Fund, LP ("Dutchess").
A new study published in April 2020 on the preprint server bioRxiv reports that the different levels of susceptibility of various organs to viral attack by the SARS-CoV-2 virus causing the huge pandemic of COVID-19 sweeping around the world can be predicted from the level of expression of two molecules, the ACE2 receptor, and the TMPRSS2 protein.
Academic and Community Cancer Research United (ACCRU) today announced the opening of a two-arm, randomized phase III, FDA registration trial of eribulin compared to standard weekly paclitaxel as first- or second-line chemotherapy for individuals with human epidermal growth factor receptor 2 (HER2) negative, locally recurrent, unresectable or metastatic breast cancer.
This research, published on Oct. 12 on the Nature review website, provides evidence of a major concept could pave the way for the future use of these stem cells to treat humans, through perspective gene therapies.
This week, Africa seizes an unprecedented chance to drive out polio when 15 countries across the continent launch a synchronized mass immunization campaign to reach 72 million children, capitalizing on gains made this year. A total of some 290 000 vaccinators have been mobilized to go door-to-door to deliver two drops of oral polio vaccine (OPV) to every child under five in areas considered at "highest risk" of polio transmission.
› Verified 7 days ago
Preetha Nair, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Boulevard, Dallas, TX 75390 Phone: 214-645-0624 Fax: 214-645-0078 | |
Michael Burton, MD, MSPH Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-645-3597 | |
Lavanya Ambujaa Dharmarajan, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 6201 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-633-5555 | |
Roshni Patel, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 8230 Walnut Hill Ln Ste 620, Dallas, TX 75231 Phone: 214-373-3475 | |
Dr. Apurva Yeluru, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3500 Gaston Ave Ste 550, Dallas, TX 75246 Phone: 214-820-0111 | |
Dr. Nicholas Ragovis, M.D. Hospitalist Medicare: Medicare Enrolled Practice Location: 5200 Harry Hines Blvd, Dallas, TX 75235 Phone: 214-590-8000 Fax: 212-289-6393 | |
Kenneth Carter Raney, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1441 N Beckley Avenue, Dept Of Medical Education, Dallas, TX 75203 Phone: 214-947-2300 |